Key Takeaways
- Rolls-Royce (RR.L) stunned markets with a massive £7B–£9B share buyback program for 2026–2028 and a significant Free Cash Flow (FCF) beat.
- Stellantis (STLA) reported a staggering €22.33B net loss for FY 2025, driven by a massive strategic "reset" and negative operating margins.
- NVIDIA (NVDA) received further price target upgrades from Morgan Stanley ($260) and RBC ($250) following strong Q1 guidance.
- China’s Ministry of Commerce reaffirmed its commitment to the February 4 trade consensus with the U.S., signaling ongoing high-level communication.
- Allianz (ALV.DE) posted a record €17.37B operating profit for FY 2025 and proposed an increased dividend of €17.10 per share.
Industrial Divergence: Rolls-Royce Soars, Stellantis Struggles
The European industrial landscape saw a dramatic split on Thursday as two of its largest players reported vastly different fortunes. Rolls-Royce (RR.L) continued its meteoric turnaround under CEO Tufan Erginbilgic, reporting an Adjusted Operating Profit of £3.46B, surpassing analyst estimates of £3.26B. The company also announced a monumental £7B–£9B share buyback scheduled across 2026–2028, underpinned by a 2026 FCF guidance of £3.6B to £3.8B, which significantly beat the consensus of £3.26B.
In sharp contrast, Stellantis (STLA) revealed the heavy toll of its strategic "reset," posting a Net Loss of €22.33B for FY 2025. This represents a massive swing from the €5.52B profit recorded the previous year, with Adjusted Operating Margins turning negative to -0.5%. The automaker attributed the loss to roughly €22.2B in charges related to resizing its EV supply chain and realigning product plans to meet shifting consumer demand and U.S. emission regulations.
Tech Momentum: NVIDIA Targets Chased Higher
NVIDIA (NVDA) remains the primary beneficiary of the ongoing AI infrastructure boom, with shares rising 1.4% in Frankfurt trading this morning. Wall Street analysts are aggressively raising their price targets following the company's robust Q1 guidance. Morgan Stanley lifted its target to $260 from $250, while RBC moved its projection to $250 from $240, citing the chipmaker's "end-to-end advantage" in the GPU and data center markets.
Market sentiment remains overwhelmingly bullish on the semiconductor giant, as analysts believe the current AI build-out is still in its early-to-mid stages. The consensus view suggests that NVIDIA's dominance in high-bandwidth memory (HBM) and advanced packaging will continue to drive outperformance through the second half of 2026.
Global Trade and Geopolitical Developments
Diplomatic signals from Beijing provided a tailwind for trade-sensitive sectors. The China Commerce Ministry stated it is actively working with the U.S. to implement the February 4 trade consensus, emphasizing that "ongoing communication" is maintained across all levels. While China remains opposed to unilateral tariffs, the ministry's commitment to the consultation mechanism suggests a period of relative stability in the bilateral relationship.
On the geopolitical front, Iranian President Masoud Pezeshkian affirmed that Iran has no intention of building nuclear weapons, stating that the nation would adhere to the Supreme Leader's religious prohibition of such arms. In Europe, social dialogue showed progress as France's SebLecornu confirmed that an agreement on unemployment insurance was reached late Wednesday, providing some domestic policy clarity for the Eurozone's second-largest economy.
Financials and Macro Outlook
Allianz (ALV.DE) solidified its position as a reliable income play, reporting a record FY Operating Profit of €17.37B, narrowly beating the €17.35B estimate. The insurer's Solvency II Ratio of 218% demonstrated exceptional capital strength, allowing for a proposed dividend of €17.10 per share. Additionally, the board resolved to initiate a new €2.5B share buyback program, further rewarding shareholders.
In other market moves, Drax Group (DRX.L) saw its price target upgraded to 1,000p by RBC, reflecting positive sentiment in the power generation sector. However, the Hang Seng Biotech Index faced significant pressure, dropping 4% in Hong Kong trading. Meanwhile, macro data from Northern Europe showed Sweden’s Household Lending growing at a steady 3.0% Y/Y in January, slightly ahead of the previous 2.9% reading.
Ed Liston is a senior contributing editor at TheStockMarketWatch.com. An active market watcher and investor, Ed guides an independent team of experienced analysts and writes for multiple stock trader publications.